European Cancer Market Outlook
European Cancer Market Outlook
RELEASE DATE
24-Jun-2011
24-Jun-2011
REGION
Europe
Europe
Research Code: M62A-01-00-00-00
SKU: HC01896-EU-MR_06931
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01896-EU-MR_06931
Description
This research service analyses the European cancer drugs therapeutics market. The base year is 2010 with forecasts running through 2017. It analyses market drivers, restraints and challenges faced by industry participants. Total revenue forecasts of the cancer drugs market in Europe and pipeline analysis have been discussed. An overview of key cancer indications and treatment options are also provided. Moreover, it provides strategic recommendations for market players. Furthermore, it provides decision support databases which is a collection of multiple tables that cover a sector's demand, supply, select customer demographics and pertinent economic measurements.
Table of Contents
Summary of the European Cancer Markets
- Executive Summary of the European Cancer Markets
Methodology of Research
- Methodology
Introduction
- Scope and Segmentation
- Assumptions and Limitations
- Glossary of Terms and Abbreviations
- Epidemiology
- Cancer Treatment Pathways
Market Trends and Dynamics
- Market Overview
- Key Trends in Cancer Therapeutics
- Key Trends in Cancer Diagnostics
- Market Engineering Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
- Revenue Forecasts
Major Cancer Types and Treatment Options
Current Therapeutic Options
- Cancer Indications - Overview
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Ovarian Cancer
- Prostate Cancer
- Pancreatic Cancer
- Hodgkin's Disease (HD) and Non-Hodgkin's Lymphoma (NHL)
- Head and Neck Cancer
Key Anti- Cancer Drug Therapeutics
Country-wise Cancer Market Analysis
Product Profiles
Strategic Analysis and Recommendations
Databases for Analysis
Related Research
Popular Topics
This research service analyses the European cancer drugs therapeutics market. The base year is 2010 with forecasts running through 2017. It analyses market drivers, restraints and challenges faced by industry participants. Total revenue forecasts of the cancer drugs market in Europe and pipeline analysis have been discussed. An overview of key cancer indications and treatment options are also provided. Moreover, it provides strategic recommendations for market players. Furthermore, it provides decision support databases which is a collection of multiple tables that cover a sector's demand, supply, select customer demographics and pertinent economic measurements.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | M62A-01-00-00-00 |
Is Prebook | No |